Product
R2R01
2 clinical trials
4 indications
Indication
Congestive Heart FailureIndication
Heart FailureIndication
Hepatorenal syndromeIndication
Acute Kidney InjuryClinical trial
A Phase 2, Double-Blind, Placebo-Controlled, Dose Range Finding Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the Relaxin Agonist R2R01 Combined With Standard of Care Versus Standard of Care Alone in Outpatients With Worsening Heart Failure (WHF)Status: Not yet recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Single-blind, Phase 2, Multi-center, Randomized Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of the R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome - Acute Kidney InjuryStatus: Recruiting, Estimated PCD: 2024-12-01